BNP Paribas Financial Markets’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $325M | Buy |
7,620,469
+2,518,663
| +49% | +$137M | 0.11% | 145 |
|
|
2026
Q1 | $320M | Buy |
5,101,806
+1,807,168
| +55% | +$145M | 0.16% | 126 |
|
|
2025
Q4 | $314M | Buy |
3,294,638
+579,679
| +21% | +$56.8M | 0.14% | 131 |
|
|
2025
Q3 | $265M | Sell |
2,714,959
-157,165
| -5% | -$16.3M | 0.14% | 124 |
|
|
2025
Q2 | $308M | Sell |
2,872,124
-332,100
| -10% | -$33.6M | 0.18% | 101 |
|
|
2025
Q1 | $323M | Buy |
3,204,224
+452,195
| +16% | +$45.5M | 0.19% | 109 |
|
|
2024
Q4 | $246M | Buy |
2,752,029
+349,445
| +15% | +$30.8M | 0.14% | 131 |
|
|
2024
Q3 | $201M | Buy |
2,402,584
+707,481
| +42% | +$55.8M | 0.14% | 151 |
|
|
2024
Q2 | $131M | Sell |
1,695,103
-42,413
| -2% | -$3.1M | 0.11% | 184 |
|
|
2024
Q1 | $119M | Buy |
1,737,516
+814,417
| +88% | +$52.4M | 0.1% | 199 |
|
|
2023
Q4 | $53.4M | Sell |
923,099
-874,193
| -49% | -$46.7M | 0.06% | 345 |
|
|
2023
Q3 | $94.9M | Buy |
1,797,292
+127,424
| +8% | +$6.68M | 0.12% | 172 |
|
|
2023
Q2 | $90.3M | Buy |
1,669,868
+974,584
| +140% | +$50.9M | 0.11% | 177 |
|
|
2023
Q1 | $34.8M | Buy |
695,284
+13,399
| +2% | +$631K | 0.05% | 406 |
|
|
2022
Q4 | $31.6M | Sell |
681,885
-497,292
| -42% | -$21.5M | 0.05% | 473 |
|
|
2022
Q3 | $45.7M | Buy |
1,179,177
+171,905
| +17% | +$6.9M | 0.07% | 309 |
|
|
2022
Q2 | $37.5M | Buy |
1,007,272
+6,146
| +0.6% | +$250K | 0.06% | 349 |
|
|
2022
Q1 | $44.3M | Buy |
1,001,126
+471,404
| +89% | +$20.4M | 0.06% | 323 |
|
|
2021
Q4 | $22.5M | Sell |
529,722
-655,307
| -55% | -$27.5M | 0.03% | 600 |
|
|
2021
Q3 | $51.4M | Buy |
1,185,029
+607,901
| +105% | +$26.9M | 0.07% | 292 |
|
|
2021
Q2 | $24.7M | Buy |
577,128
+170,731
| +42% | +$7.18M | 0.03% | 566 |
|
|
2021
Q1 | $15.7M | Sell |
406,397
-201,734
| -33% | -$7.64M | 0.02% | 629 |
|
|
2020
Q4 | $21.9M | Sell |
608,131
-375,008
| -38% | -$13.5M | 0.04% | 462 |
|
|
2020
Q3 | $37.6M | Buy |
983,139
+311,714
| +46% | +$12M | 0.05% | 336 |
|
|
2020
Q2 | $23.6M | Sell |
671,425
-374,929
| -36% | -$13.5M | 0.04% | 394 |
|
|
2020
Q1 | $34.1M | Buy |
1,046,354
+563,394
| +117% | +$22M | 0.07% | 261 |
|
|
2019
Q4 | $21.8M | Buy |
482,960
+381,900
| +378% | +$16M | 0.04% | 466 |
|
|
2019
Q3 | $4.11M | Sell |
101,060
-62,760
| -38% | -$2.66M | 0.01% | 1159 |
|
|
2019
Q2 | $7.04M | Buy |
163,820
+66,808
| +69% | +$2.57M | 0.01% | 887 |
|
|
2019
Q1 | $3.72M | Sell |
97,012
-133,233
| -58% | -$5.09M | 0.01% | 1114 |
|
|
2018
Q4 | $8.14M | Sell |
230,245
-198,162
| -46% | -$7.19M | 0.02% | 729 |
|
|
2018
Q3 | $16.5M | Sell |
428,407
-51,848
| -11% | -$1.81M | 0.02% | 611 |
|
|
2018
Q2 | $15.7M | Sell |
480,255
-113,373
| -19% | -$3.42M | 0.03% | 602 |
|
|
2018
Q1 | $16.2M | Sell |
593,628
-453,616
| -43% | -$12.3M | 0.03% | 521 |
|
|
2017
Q4 | $26M | Buy |
1,047,244
+211,615
| +25% | +$5.84M | 0.05% | 364 |
|
|
2017
Q3 | $24.4M | Sell |
835,629
-60,134
| -7% | -$1.66M | 0.06% | 289 |
|
|
2017
Q2 | $24.8M | Sell |
895,763
-848,328
| -49% | -$22.5M | 0.07% | 257 |
|
|
2017
Q1 | $43.4M | Buy |
1,744,091
+1,315,874
| +307% | +$32M | 0.11% | 173 |
|
|
2016
Q4 | $9.26M | Buy |
428,217
+354,224
| +479% | +$7.73M | 0.04% | 371 |
|
|
2016
Q3 | $1.76M | Sell |
73,993
-21,531
| -23% | -$514K | 0.01% | 762 |
|
|
2016
Q2 | $2.23M | Sell |
95,524
-143,295
| -60% | -$3.1M | 0.01% | 813 |
|
|
2016
Q1 | $4.49M | Buy |
238,819
+141,054
| +144% | +$2.48M | 0.02% | 601 |
|
|
2015
Q4 | $1.8M | Buy |
97,765
+96,842
| +10,492% | +$1.74M | ﹤0.01% | 957 |
|
|
2015
Q3 | $15.1K | Sell |
923
-72,709
| -99% | -$1.24M | ﹤0.01% | 3363 |
|
|
2015
Q2 | $1.3M | Sell |
73,632
-231,655
| -76% | -$4.14M | ﹤0.01% | 1044 |
|
|
2015
Q1 | $5.42M | Sell |
305,287
-814,886
| -73% | -$12.9M | 0.02% | 593 |
|
|
2014
Q4 | $14.8M | Sell |
1,120,173
-398,724
| -26% | -$5.1M | 0.05% | 314 |
|
|
2014
Q3 | $17.9M | Buy |
1,518,897
+284,574
| +23% | +$3.58M | 0.02% | 345 |
|
|
2014
Q2 | $15.8M | Sell |
1,234,323
-141,107
| -10% | -$1.83M | 0.01% | 304 |
|
|
2014
Q1 | $17.3M | Buy |
1,375,430
+529,966
| +63% | +$6.96M | 0.01% | 313 |
|
|
2013
Q4 | $10.2M | Sell |
845,464
-48,333
| -5% | -$571K | 0.01% | 470 |
|
|
2013
Q3 | $10.5M | Buy |
893,797
+705,181
| +374% | +$7.63M | 0.01% | 506 |
|
|
2013
Q2 | $1.75M | Buy |
+188,616
| New | +$1.6M | ﹤0.01% | 786 |
|
Other funds holding BSX
VCM
VPM
BNP Paribas Financial Markets's BSX Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Boston Scientific (BSX) stake by 49% in Q2 2026, buying an estimated $137M and bringing the position to 7,620,469 shares worth $325M. The position accounts for 0.11% of the portfolio, ranked #145.
BNP Paribas Financial Markets first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. 1,176 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- BNP Paribas Financial Markets held 7,620,469 shares of Boston Scientific worth $325M as of Q2 2026.
- BNP Paribas Financial Markets bought 2,518,663 Boston Scientific shares in Q2 2026, an estimated $137M.
- Boston Scientific made up 0.11% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #145 holding.
- BNP Paribas Financial Markets first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- 1,176 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.